Vitamina K1
A fat-soluble vitamin that acts as an essential cofactor in the hepatic synthesis of vitamin K-dependent clotting factors (II, VII, IX, and X), promoting hemostasis and proper blood coagulation.
TARGET SPECIES
DOSAGE FORM
HOW SUPPLIED
DIFFERENTIATORS
BENEFITS AND COMPETITIVE ADVANTAGES
Broad spectrum of use across various animal species.
Versatile administration routes: SC, IM, or slow IV.
Broad spectrum of use across various animal species.
Oral administration (newly approved route of administration).
TECHNICAL DETAILS
Information
COMPOSITION
– Excipients q.s. to 1 mL.
DOSAGE AND ADMINISTRATION
In cases of acute hypoprothrombinemia, administer intravenously (IV) at a rate not exceeding 10 mg per minute in adult cattle, horses, pigs, sheep, and goats, or 5 mg per minute in young or newborn animals and dogs and cats.
In non-acute cases, administer intramuscularly (IM) or subcutaneously (SC).
The oral route is recommended exclusively in dogs and cats after initiation of parenteral treatment and until prothrombin time normalizes.
Dosage and treatment duration may be adjusted based on the clinical picture, at the discretion of the attending veterinary professional.
- Joint Health
- Opioid Pain Management
- NSAID Pain Management
- Neuropathic Pain
- Steroidal Anti-inflammatory Drugs
- Antibiotics
- Gastrointestinal Health
- Hepatic Health
- Integrative Functional Supplementation
- Vitamins and Minerals
- Omega
- Laxatives
- Anticholinergic – Antispasmodics
- Hemostatic Agents
- Internal Antiparasitics
- External Antiparasitics
- Hemostatic Agent
Vitamina K1
TARGET SPECIES
DOSAGE FORM
HOW SUPPLIED
A fat-soluble vitamin that acts as an essential cofactor in the hepatic synthesis of vitamin K-dependent clotting factors (II, VII, IX, and X), promoting hemostasis and proper blood coagulation.
Broad spectrum of use across various animal species.
Versatile administration routes: SC, IM, or slow IV.
Broad spectrum of use across various animal species.
Oral administration (newly approved route of administration).
TECHNICAL DETAILS
Information
COMPOSITION
– Excipients q.s. to 1 mL.
DOSAGE AND ADMINISTRATION
In cases of acute hypoprothrombinemia, administer intravenously (IV) at a rate not exceeding 10 mg per minute in adult cattle, horses, pigs, sheep, and goats, or 5 mg per minute in young or newborn animals and dogs and cats.
In non-acute cases, administer intramuscularly (IM) or subcutaneously (SC).
The oral route is recommended exclusively in dogs and cats after initiation of parenteral treatment and until prothrombin time normalizes.
Dosage and treatment duration may be adjusted based on the clinical picture, at the discretion of the attending veterinary professional.
